[1]
|
Torre, L.A., Trabert, B., Desantis, C.E., Miller, K.D., Samimi, G., Runowicz, C.D., et al. (2018) Ovarian Cancer Statistics. CA: A Cancer Journal for Clinicians, 68, 284-296. https://doi.org/10.3322/caac.21456
|
[2]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[3]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2018) Cancer Statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 7-30. https://doi.org/10.3322/caac.21442
|
[4]
|
Kim, S.R., Kotsopoulos, J., Sun, P., Bernardini, M.Q., Laframboise, S. and Ferguson, S.E. (2021) The Impacts of Neoadjuvant Chemotherapy and of Cytoreductive Surgery on 10-year Survival from Advanced Ovarian Cancer. International Journal of Gynecology & Obstetrics, 153, 417-423. https://doi.org/10.1002/ijgo.13542
|
[5]
|
Machida, H., Tokunaga, H., Matsuo, K., Matsumura, N., Kobayashi, Y. Tabata, T., et al. (2020) Survival Outcome and Perioperative Complication Related to Neoadjuvant Chemotherapy with Carboplatin and Paclitaxel for Advanced Ovarian Cancer: A Systematic Review and Meta-Analysis. European Journal of Surgical Oncology, 46, 868-875. https://doi.org/10.1016/j.ejso.2019.11.520
|
[6]
|
Ataseven, B., Chiva, L.M., Harter, P., Gonzalez-Martin, A. and du Bois, A. (2016) FIGO Stage IV Epithelial Ovarian, Fallopian Tube and Peritoneal Cancer Revisited. Gynecologic Oncology, 142, 597-607. https://doi.org/10.1016/j.ygyno.2016.06.013
|
[7]
|
Kumar, L., Pramanik, R., Kumar, S., Bhatla, N. and Malik, S. (2015) Neoadjuvant Chemotherapy in Gynaecological Cancers—Implications for Staging. Best Practice & Research Clinical Obstetrics & Gynaecology, 29, 790-801. https://doi.org/10.1016/j.bpobgyn.2015.02.008
|
[8]
|
Park, S.J., Kim, J., Kim, S.N., Lee, E.J., Oh, S., Seol, A., et al. (2019) Practice Patterns of Surgery for Advanced Ovarian Cancer: Analysis from International Surveys. Japanese Journal of Clinical Oncology, 49, 137-145. https://doi.org/10.1093/jjco/hyy175
|
[9]
|
Liberale, G., Pop, C.F., Polastro, L., Kerger, J., Moreau, M., Chintinne, M., et al. (2020) A Radical Approach to Achieve Complete Cytoreductive Surgery Improve Survival of Patients with Advanced Ovarian Cancer. Journal of Visceral Surgery, 157, 79-86. https://doi.org/10.1016/j.jviscsurg.2019.12.002
|
[10]
|
Sorensen, S.M., Schnack, T.H. and Hogdall, C. (2019) Impact of Residual Disease on Overall Survival in Women with Federation of Gynecology and Obstetrics Stage IIIB-IIIC vs Stage IV Epithelial Ovarian Cancer after Primary Surgery. Acta Obstetricia et Gynecologica Scandinavica, 98, 34-43. https://doi.org/10.1111/aogs.13453
|
[11]
|
Greer, A., Gockley, A., Manning-Geist, B., Melamed, A., Sisodia, R.C., Berkowitz, R., et al. (2021) Impact of Residual Disease at Interval Debulking Surgery on Platinum Resistance and Patterns of Recurrence for Advanced-Stage Ovarian Cancer. International Journal of Gynecological Cancer, 31, 1341-1347. https://doi.org/10.1136/ijgc-2020-001505
|
[12]
|
du Bois, A., Reuss, A., Pujade-Lauraine, E., Harter, P., Ray-Coquard, I. and Pfisterer, J. (2009) Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer, 115, 1234-1244. https://doi.org/10.1002/cncr.24149
|
[13]
|
Brand, A.H. (2011) Ovarian Cancer Debulking Surgery: A Survey of Practice in Australia and New Zealand. International Journal of Gynecological Cancer, 21, 230-235. https://doi.org/10.1097/IGC.0b013e318205fb4f
|
[14]
|
Dottino, J.A., He, W., Sun, C.C., Zhao, H., Fu, S., Rauh-Hain, J.A., et al. (2020) National Trends in Bowel and Upper Abdominal Procedures in Ovarian Cancer Surgery. International Journal of Gynecological Cancer, 30, 1195-1202. https://doi.org/10.1136/ijgc-2020-001243
|
[15]
|
Jones, N.L., Chen, L., Chatterjee, S., Tergas, A.I., Burke, W.M., Hou, J.Y., et al. (2018) National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery. International Journal of Gynecological Cancer, 28, 19-25. https://doi.org/10.1097/IGC.0000000000001132
|
[16]
|
Chi, D.S., Eisenhauer, E.L., Zivanovic, O., Sonoda, Y., Abu-Rustum, N.R., Levine, D.A., et al. (2009) Improved Progression-Free and Overall Survival in Advanced Ovarian Cancer as a Result of a Change in Surgical Paradigm. Gynecologic Oncology, 114, 26-31. https://doi.org/10.1016/j.ygyno.2009.03.018
|
[17]
|
Barlin, J.N., Long, K.C., Tanner, E.J., Gardner, G.J., Leitao, M.J., Levine, D.A., et al. (2013) Optimal (≤1 cm) But Visible Residual Disease: Is Extensive Debulking Warranted? Gynecologic Oncology, 130, 284-288. https://doi.org/10.1016/j.ygyno.2013.05.006
|
[18]
|
Tozzi, R., Traill, Z., Garruto, C.R., Ferrari, F., Soleymani, M.H., Nieuwstad, J., et al. (2016) Porta Hepatis Peritonectomy and Hepato-Celiac Lymphadenectomy in Patients with Stage IIIC-IV Ovarian Cancer: Diagnostic Pathway, Surgical Technique and Outcomes. Gynecologic Oncology, 143, 35-39. https://doi.org/10.1016/j.ygyno.2016.08.232
|
[19]
|
Chi, D.S., Zivanovic, O., Levinson, K.L., Kolev, V., Huh, J., Dottino, J., et al. (2010) The Incidence of Major Complications after the Performance of Extensive Upper Abdominal Surgical Procedures during Primary Cytoreduction of Advanced Ovarian, Tubal, and Peritoneal Carcinomas. Gynecologic Oncology, 119, 38-42. https://doi.org/10.1016/j.ygyno.2010.05.031
|
[20]
|
Yalcin, Y., Tatar, B., Erdemoglu, E. and Erdemoglu, E. (2019) The Parameters to Estimate Postoperative Severe Complications Classified through Clavien-Dindo after Upper Abdominal Surgery in Patients with Primary and Recurrent Ovarian Cancer. Ginekologia Polska, 90, 557-564. https://doi.org/10.5603/GP.2019.0097
|
[21]
|
Benedetti, P.P., Di Donato, V., Fischetti, M., Casorelli, A., Perniola, G., Musella, A., et al. (2015) Predictors of Postoperative Morbidity after Cytoreduction for Advanced Ovarian Cancer: Analysis and Management of Complications in Upper Abdominal Surgery. Gynecologic Oncology, 137, 406-411. https://doi.org/10.1016/j.ygyno.2015.03.043
|
[22]
|
Bogani, G., Ditto, A., Martinelli, F., Lorusso, D., Chiappa, V., Donfrancesco, C., et al. (2016) Surgical Techniques for Diaphragmatic Resection during Cytoreduction in Advanced or Recurrent Ovarian Carcinoma: A Systematic Review and Meta-Analysis. The International Journal of Gynecological Cancer, 26, 371-380. https://doi.org/10.1097/IGC.0000000000000597
|
[23]
|
Eisenhauer, E.L., D’Angelica, M.I., Abu-Rustum, N.R., Sonoda, Y., Jarnagin, W.R., Barakat, R.R. and Chi, D.S. (2006) Incidence and Management of Pleural Effusions after Diaphragm Peritonectomy or Resection for Advanced Mullerian Cancer. Gynecologic Oncology, 103, 871-877. https://doi.org/10.1016/j.ygyno.2006.05.023
|
[24]
|
Ye, S., He, T., Liang, S., Chen, X., Wu, X.H., Yang, H.J. and Xiang, L.B. (2017) Diaphragmatic Surgery and Related Complications in Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma. BMC Cancer, 17, Article No. 317. https://doi.org/10.1186/s12885-017-3311-8
|
[25]
|
Datta, A., Sebastian, A., Chandy, R.G., Thomas, V., Thomas, D.S., Karuppusami, R., et al. (2021) Complications and Outcomes of Diaphragm Surgeries in Epithelial Ovarian Malignancies. Indian Journal of Surgical Oncology, 12, 822-829. https://doi.org/10.1007/s13193-021-01438-x
|
[26]
|
Kato, K., Katsuda, T. and Takeshima, N. (2016) Cytoreduction of Diaphragmatic Metastasis from Ovarian Cancer with Involvement of the Liver Using a Ventral Liver Mobilization Technique. Gynecologic Oncology, 140, 577-579. https://doi.org/10.1016/j.ygyno.2016.01.017
|
[27]
|
Deng, K., Yang, C., Tan, Q., Song, W., Lu, M., Zhao, W., et al. (2018) Sites of Distant Metastases and Overall Survival in Ovarian Cancer: A Study of 1481 Patients. Gynecologic Oncology, 150, 460-465. https://doi.org/10.1016/j.ygyno.2018.06.022
|
[28]
|
Kamel, S.I., de Jong, M.C., Schulick, R.D., Diaz-Montes, T.P., Wolfgang, C.L., Hirose, K., et al. (2011) The Role of Liver-Directed Surgery in Patients with Hepatic Metastasis from a Gynecologic Primary Carcinoma. World Journal of Surgery, 35, 1345-1354. https://doi.org/10.1007/s00268-011-1074-y
|
[29]
|
Rodriguez, N., Miller, A., Richard, S.D., Rungruang, B., Hamilton, C.A., Bookman, M.A., et al. (2013) Upper Abdominal Procedures in Advanced Stage Ovarian or Primary Peritoneal Carcinoma Patients with Minimal or No Gross Residual Disease: An Analysis of Gynecologic Oncology Group (GOG) 182. Gynecologic Oncology, 130, 487-492. https://doi.org/10.1016/j.ygyno.2013.06.017
|
[30]
|
Bristow, R.E., Tomacruz, R.S., Armstrong, D.K., Trimble, E.L. and Montz, F.J. (2002) Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma during the Platinum Era: A Meta-Analysis. Journal of Clinical Oncology, 20, 1248-1259. https://doi.org/10.1200/JCO.2002.20.5.1248
|
[31]
|
Wang, M., Zhou, J., Zhang, L., Zhao, Y., Zhang, N., Wang, L., et al. (2019) Surgical Treatment of Ovarian Cancer Liver Metastasis. Hepatobiliary Surgery and Nutrition, 8, 129-137. https://doi.org/10.21037/hbsn.2018.12.06
|
[32]
|
Gasparri, M.L., Grandi, G., Bolla, D., Gloor, B., Imboden, S., Panici, P.B., Mueller, M.D. and Papadia, A. (2016) Hepatic Resection during Cytoreductive Surgery for Primary or Recurrent Epithelial Ovarian Cancer. Journal of Cancer Research and Clinical Oncology, 142, 1509-1520. https://doi.org/10.1007/s00432-015-2090-3
|
[33]
|
Luna-Abanto, J., Garcia, R.L., Laura, M.J., Alvarez, L.M. and Villoslada, T.V. (2020) Liver Resection as Part of Cytoreductive Surgery for Ovarian Cancer. Journal of Gynecologic Surgery, 36, 70-75. https://doi.org/10.1089/gyn.2019.0074
|
[34]
|
Durmus, Y., Isci, B.E., Duru, C.A., Kayikcioglu, F. and Boran, N. (2019) Metastasis Patterns of the Spleen and Association with Survival Outcomes in Advanced Ovarian-Tubal-Peritoneal Epithelial Cancer. Archives of Gynecology and Obstetrics, 300, 1367-1375. https://doi.org/10.1007/s00404-019-05300-y
|
[35]
|
Dagbert, F., Thievenaz, R., Decullier, E., Bakrin, N., Cotte, E., Rousset, P., et al. (2016) Splenectomy Increases Postoperative Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology, 23, 1980-1985. https://doi.org/10.1245/s10434-016-5147-x
|
[36]
|
Said, S.A., van der Aa, M.A., Veldmate, G., de Hullu, J.A. and van Altena, A.M. (2022) Oncologic Outcomes after Splenectomy during Initial Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer: A Nationwide Population-Based Cohort Study. Acta Obstetricia et Gynecologica Scandinavica, 101, 56-67. https://doi.org/10.1111/aogs.14286
|
[37]
|
Timmermans, M., van der Aa, M.A., Lalisang, R.I., Witteveen, P.O., Van de Vijver, K.K., Kruitwagen, R.F. and Sonke, G.S. (2018) Interval between Debulking Surgery and Adjuvant Chemotherapy Is Associated with Overall Survival in Patients with Advanced Ovarian Cancer. Gynecologic Oncology, 150, 446-450. https://doi.org/10.1016/j.ygyno.2018.07.004
|
[38]
|
Munkarah, A., Levenback, C., Wolf, J.K., Bodurka-Bevers, D., Tortolero-Luna, G., Morris, R.T. and Gershenson, D.M. (2001) Secondary Cytoreductive Surgery for Localized Intra-Abdominal Recurrences in Epithelial Ovarian Cancer. Gynecologic Oncology, 81, 237-241. https://doi.org/10.1006/gyno.2001.6143
|
[39]
|
Son, J.H. and Chang, S.J. (2021) Extrapelvic Bowel Resection and Anastomosis in Cytoreductive Surgery for Ovarian Cancer. Gland Surgery, 10, 1207-1211. https://doi.org/10.21037/gs-2019-ursoc-01
|
[40]
|
Bachmann, R., Rothmund, R., Kramer, B., Brucker, S.Y., Konigsrainer, A., Konigsrainer, I., et al. (2015) The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer. Journal of Investigative Surgery, 28, 160-166. https://doi.org/10.3109/08941939.2014.994794
|
[41]
|
Sebastian, A., Thomas, A., Varghese, G., Yadav, B., Chandy, R. and Peedicayil, A. (2018) Outcome of Bowel Resection in Women with Advanced Ovarian Carcinoma. Indian Journal of Surgical Oncology, 9, 511-518. https://doi.org/10.1007/s13193-018-0790-2
|
[42]
|
Derlatka, P., Sienko, J., Grabowska-Derlatka, L., Palczewski, P., Danska-Bidzinska, A., Bidzinski, M. and Czajkowski, K. (2016) Results of Optimal Debulking Surgery with Bowel Resection in Patients with Advanced Ovarian Cancer. World Journal of Surgical Oncology, 14, Article No. 58. https://doi.org/10.1186/s12957-016-0800-1
|
[43]
|
Mcnamara, B., Guerra, R., Qin, J., Craig, A.D., Chen, L.M., Varma, M.G. and Chapman, J.S. (2021) Survival Impact of Bowel Resection at the Time of Interval Cytoreductive Surgery for Advanced Ovarian Cancer. Gynecologic Oncology Reports, 38, Article 100870. https://doi.org/10.1016/j.gore.2021.100870
|
[44]
|
Abdul, S., Tidy, J.A. and Paterson, M.E. (2006) Can We Identify the Patients Who Are Likely to Undergo Bowel Resection at the Time of Surgery for Ovarian Cancer? Journal of Obstetrics and Gynaecology, 26, 357-362. https://doi.org/10.1080/01443610600613565
|
[45]
|
Kim, M., Suh, D.H., Park, J.Y., Paik, E.S., Lee, S. and Eoh, K.J. (2018) Survival Impact of Low Anterior Resection in Patients with Epithelial Ovarian Cancer Grossly Confined to the Pelvic Cavity: A Korean Multicenter Study. Journal of Gynecological Oncology, 29, e60. https://doi.org/10.3802/jgo.2018.29.e6
|
[46]
|
Oseledchyk, A., Hunold, L.E., Mallmann, M.R., Domrose, C.M., Abramian, A., Debald, M. et al. (2016) Impact of Extended Primary Surgery on Suboptimally Operable Patients with Advanced Ovarian Cancer. International Journal of Gynecological Cancer, 26, 873-883. https://doi.org/10.1097/IGC.0000000000000707
|
[47]
|
Winter, W.R., Maxwell, G.L., Tian, C., Sundborg, M.J., Rose, G.S., Rose, P.G., et al. (2008) Tumor Residual after Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study. Journal of Clinical Oncology, 26, 83-89. https://doi.org/10.1200/JCO.2007.13.1953
|
[48]
|
Harter, P., Sehouli, J., Lorusso, D., Reuss, A., Vergote, I., Marth, C., et al. (2019) A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms. The New England Journal of Medicine, 380, 822-832. https://doi.org/10.1056/NEJMoa1808424
|
[49]
|
Frenzel, F., Hollaender, S., Fries, P., Stroeder, R. and Stroeder, J. (2020) Jejunal Obstruction Due to Rare Internal Hernia between Skeletonized External Iliac Artery and Vein as Late Complication of Laparoscopic Hysterectomy with Pelvic Lymphadenectomy—Case Report and Review of Literature. Archives of Gynecology and Obstetrics, 302, 1075-1080. https://doi.org/10.1007/s00404-020-05724-x
|
[50]
|
Paik, E.S., Shim, M., Choi, H.J., Lee, Y.Y., Kim, T.J., Lee, J.W., et al. (2016) Impact of Lymphadenectomy on Survival after Recurrence in Patients with Advanced Ovarian Cancer without Suspected Lymph Node Metastasis. Gynecologic Oncology, 143, 252-257. https://doi.org/10.1016/j.ygyno.2016.08.321
|
[51]
|
du Bois, A., Reuss, A., Harter, P., Pujade-Lauraine, E., Ray-Coquard, I. and Pfisterer, J. (2010) Potential Role of Lymphadenectomy in Advanced Ovarian Cancer: A Combined Exploratory Analysis of Three Prospectively Randomized Phase III Multicenter Trials. Journal of Clinical Oncology, 28, 1733-1739. https://doi.org/10.1200/JCO.2009.25.3617
|
[52]
|
Maggioni, A., Benedetti, P.P., Dell’Anna, T., Landoni, F., Lissoni, A., Pellegrino, A., et al. (2006) Randomised Study of Systematic Lymphadenectomy in Patients with Epithelial Ovarian Cancer Macroscopically Confined to the Pelvis. British Journal of Cancer, 95, 699-704. https://doi.org/10.1038/sj.bjc.6603323
|